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The term “omics” refers to the comprehensive analysis of a specific biological system. With the development of omics, a number 
of omics subdisciplines have emerged, which play an important role in system biology. As a subdiscipline of omics, metabolom-
ics provides a comprehensive analysis of the metabolome and has been widely applied to various fields of biology. In this paper, 
we introduce the concept, approaches, applications, and promising prospects of metabolomics. 
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The complete sequencing of the human genome has intro-
duced a new field of systems biology, known as omics. In 
biology, the term “omics”, which means the totality of sorts, 
refers to the comprehensive analysis of a specific biological 
system. For example, “genomics” is the study of all the 
genes of a cell or tissue at the DNA (genotype), mRNA 
(transcriptome) or protein (proteome) level [1]. Omics is an 
integrated concept that combines all the information ac-
quired from the different levels at which biological systems 
are controlled to investigate the nature of biological phe-
nomena at the molecular level. Compared with traditional 
biological ideology, omics places more emphasis on the 
integration of diverse bioinformation. Thus, it provides a 
general view of processes rather than detailed information 
on the independent behaviors of specific cells or tissues. To 
date, a range of omics subdisciplines have emerged, includ-
ing genomics and proteomics, each of which has its own set 
of instruments, techniques, reagents, and software. Omics 
technology has driven the development of new research 
approaches, including DNA and protein chips, mass spec-
trometry, and instruments that enable high-throughput analy-   
sis. Omics not only offers the advantage of understanding 
biological processes, but the prospect of more accurate di-
agnoses, improvements in nutrition and other new applica-
tions in biological fields.  
Nicholson first propounded the concept of metabonomics 
in 1999. The primary definition of metabonomics is “the 
quantitative measurement of the dynamic multiparametric 
metabolic response of living systems to pathophysiological 
stimuli or genetic modification” [2]. Metabonomics focuses 
on understanding the global biological system by the study 
of metabolic compounds. The early study of metabonomics 
was focused primarily on the application of nuclear mag-
netic resonance spectroscopy (NMR) to analyze the changes 
of metabolic compounds in biological fluids, cells, and tis-
sues, and was “aimed at the augmentation and complemen-
tation of the information provided by measuring the genetic 
and proteomic responses to xenobiotic exposure” [2].  
Another important subject in the study of metabolic 
compounds is metabolomics. The focus of metabolomics is 
the compositional analysis of low molecular-weight sub-
stance in biological samples. This approach traditionally 
uses MS (Mass Spectrometry) in combination with a sepa-
ration technique such as gas chromatography (GC) or liquid 
chromatography (LC) to analyze information from low mo-
lecular-weight compounds. To avoid interaction between 
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the compounds being measured in the matrix, sample prep-
aration and analysis is focused on a series of compounds 
that share similar properties. The comprehensive identifica-
tion and quantification of the metabolic compounds synthe-
sized by an organism means that metabolomics is one of the 
most important approaches to study genetic expression and 
proteomics.  
Although there is conceptual similarity between the 
fields of metabonomics and metabolomics, there are some 
significant differences in the approaches and objectives of 
the research. The former is dedicated to comprehensive 
metabonomics profiling at a given scale, whereas the latter 
is primarily concerned with the history of time-dependent 
metabolic profiles in an integrated system [3]. However, 
associated with the development of bioinformatics, the two 
concepts will likely be integrated. For convenience, we use 
the term metabolomics in the following discussion. 
An organism is an integrated and networked system with 
a bioinformatics transport chain consisting of genes-proteins- 
metabolic compounds. Genes and proteins provide infor-
mation about what will happen, whereas metabolic com-
pounds provide information about what has happened. In 
comparison with other omics subdisciplines, metabolomics 
is defined by the following unique characteristics: (1) Met-
abolic data do not provide the information produced by the 
independent behaviors of specific cells or tissues but, in-
stead, documents the global changes of metabolome under 
the external interference, which reflect the metabolic re-
sponse to exogenous stimuli in a general view. (2) Metabol-
ic compounds are the endpoint of functional gene activity. 
According to Johnson’s research, metabolic throughput is 
not only controlled by genetic expression, but also adjusted 
by the exogenous environment [4]. The changes in concen-
trations of metabolic compounds illustrate the biological 
response to perturbation from outside. Therefore, metabolic 
compounds are more sensitive compared with genes and 
proteins. (3) During a biochemical reaction, the concentra-
tion of enzymes and metabolic throughput is generally un-
changed, whereas the concentration of some low-molecular 
weight compounds will change significantly. Being the 
endpoint of the bioinformatic transport chain, the signal 
generated by alteration of the metabolome is magnified and 
can provide insight and accurate characterization of the 
cells’ function [5]. 
1  Progress in metabolomics 
1.1  Pharmacotoxicology 
Pharmacotoxicology involves studying the toxicity of drugs, 
their effect on target organs, their latency, and the relation-
ship between structure and toxicity. After being taken into 
an organism, a heterologous substance acts directly on the 
metabolome, but has no apparent effect on the genome or 
proteome. Thus, there is little value in using genomics and 
proteomics to evaluate the mechanisms of drug toxicity. 
Traditional drug screening depends primarily on biological 
screening, which is reliant on large sample sizes and is time 
consuming. The advent of high throughout metabolomics 
technologies means it is now possible to analyze large 
numbers of samples in a relatively short period of time. Using 
metabolomics technologies, we are able to detect abnormal 
changes in trace materials in biofluids such as urine, serum, 
and tissue biopsies following exposure to a heterologous 
substance. In addition, these technologies allow for simul-
taneous quantification of total metabolic compounds. For 
example, Zhou et al. [6] injected dexamethasone into a 
group of mice at day 17.5 of pregnancy then collected 
1H-NMR spectra data for plasma metabolites. Using this 
data, Zhou et al. [6] calculated the rate of uptake in embryos 
with/without cleft palate. Based on principle component 
analysis (PCA) and Soft Independent Modeling of Class 
Analogy (SIMCA), the result showed that the rate of uptake 
differed significantly in embryos with cleft palate. Zhou et 
al. [6] demonstrates the power of the metabolomics ap-
proach in detecting abnormalities in maternal metabolites 
during gestation, and supports the author’s hypothesis that 
the presence of dexamethasone in maternal metabolites 
contributes to the occurrence of cleft palate. 
Metabolomics uses biochemical phenotypes to analyze 
the integrated functioning of an organism, while traditional 
Chinese medicine combines the alteration of the outward 
manifestation and abstract immanence to study the function 
of a specific system. Thus, both approaches share a similar 
philosophy [7]. Metabolomics can be used to evaluate the 
pharmacotoxicology of traditional Chinese medicine. For 
example, Ma et al. [8] fed mice an extract of Morning Glory 
seed (MGS). Urinary samples from control and MGS treat-
ed rats were analyzed by ultra-performance liquid chroma-
tography/mass spectrometry (UPLC-MS). Blood biochem-
istry and histopathology were examined for signs of renal 
damage. Treatment with MGS caused a significant change 
in eight metabolic compounds, regarded as biomarkers, 
demonstrating that MGS causes nephrotoxicity. This exam-
ple illustrates the potential of UPLC-MS based metabo-     
lomics for mapping the metabolic response to toxicant ex-
posure. 
1.2  Clinical diagnosis 
Using metabolomics technologies, we can acquire metabolic 
data from patient and control populations to isolate bi-
omarkers for disease. This information aids in the under-
standing of the pathogenic mechanisms of a specific disease 
and provides important clues for clinical diagnosis and 
treatment. Traditional clinical diagnosis depends on the man-
ifestation of early symptoms, which almost always delays 
the prognosis and treatment. The biological liquid circulat-
ing in an organism is in a state of homeostasis. Therefore, 
any alteration of specific metabolic compounds produced by 
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the disturbance of homeostasis provides evidence to diag-
nose illnesses. To date, metabolomics has been applied to 
the clinical diagnosis of diabetes, tumors, cardiovascular and 
cerebrovascular diseases, and the assessment of organ graft 
quality and function before transplantation. Marchesi et al. 
[9] combined high resolution 1H-NMR spectroscopy and 
multivariate pattern recognition to analyze the fecal extracts 
of both Crohn’s disease (CD) and Ulcerative colitis (UC) 
patients. The fecal extracts of both CD and UC patients 
were characterized by reduced levels of butyrate, acetate, 
methylamine, and trimethylamine in comparison with a con-
trol population, and elevated quantities of amino acids. This 
example demonstrates a number of advantages of metabo-
lomics, namely that it allows for noninvasive diagnoses and 
rapid and accurate analysis of low quality samples. 
A number of factors, including stress, changes in the en-
vironment, and radiation have no apparent effect on peo-
ple’s health. These factors can cause dysfunction and sub-
clinical injury in organs and are hard to diagnose. However, 
abnormal changes in biomarkers in a number of metabolic 
pathways can be measured to determine the effect on an 
individual. For example, Chen et al. [10] used fluorescence 
difference gel electrophoresis combined with matrix assist-
ed laser desorption ionization/time of flight MS (MALDI- 
TOF-MS) and 1H-NMR to monitor the intracellular pro-
cesses in the rat liver at the proteomic and metabonomic 
levels following restraint stress for 8 weeks. The authors 
observed elevated levels of lactate, fatty acid, glucose, and 
homocysteine in the livers of treated rats. Thus, the data 
confirm that restraint stress can cause subclinical hepatic 
injury, including inhibition of glycolysis and gluconeogene-
sis and dysfunction of fatty acid -oxidation.  
1.3  Hyphenate with genomics 
With the development of genomics, the emphasis of ge-
nomic research has shifted gradually from the sequencing of 
genomes to the expression of the functional genome. The 
functions of the hereditable information in the genome, the 
expression and regulation of the proteome, and metabolic 
perturbations reflect the hierarchy of the bioinformation 
transport chain. As the endpoint of genomic expression, 
metabolomics reflects the intact state of functional genetic 
activities. This information aids biomolecular scientists in 
the comprehensive study of biological phenomena and the 
essence of life. Currently, such research is focused primarily 
on plant metabolomics. The objective is to measure the 
metabolic response caused by genovariation and alterations 
in the environment to determine the function of silent genes 
and the relationship between genotype and phenotype, and 
collect more information about the metabolic pathway of 
plant. Taylor et al. [11] and Fiehn [12] used GC-MS to de-
tect 443 metabolic compounds in different genotypes of 
Arabidopsis and PCA and Artificial Neural Network (ANN) 
to analyze and classify the data. The authors found 4  
metabolic compounds (malic acid, citric acid, glucose, and 
fructose) that could be used as criteria for classification. 
Using antisense mediated down-regulation and overexpres-
sion of the Rpd3 gene (ZmRpd3) in the genome of an inbred 
maize line, Castro et al. [13] identified differences in me-
tabolites between sample classes that could be directly inte-
grated into the evolution of metabolic perturbation over 
time in the model. Moreover, the authors noted that major 
differences existed at the beginning of development, vali-
dating the hypothesis that ZmRpd3 transcription and pro-
teins accumulation occurs during the initial stage of devel-
opment, suggesting a role for this gene in cell cycle control. 
Metabolomics has also been used to analyze the meta-
bolic response after knocking out specific genes with the 
purpose of exploiting the relationship between the genotype 
and phenotype in transgenic animals. For example, Rull et al. 
used 1H-NMR spectroscopy to assess the metabolic function 
of the MCP-1 gene in transgenetic mice [14]. The data sug-
gest that MCP-1 plays an important role, not only in macro-
phage migration, but also in lipid and glucose metabolism.  
1.4  Nutriology 
The current focus of nutrition science is on improving the 
health of individuals through diet. Thus, the goal of most 
research is to promote health, prevent disease, and improve 
performance [15]. Conventional tools for measuring dietary 
exposure depend primarily on food composition tables to 
allow estimation of intake of energy, nutrients, and non- 
nutrient food constituents. The accuracy of this method is 
always affected by an unknown degree of misreporting. 
Metabolomics allows the simultaneous monitoring of mul-
tiple and dynamic components of biological fluids, so can 
be used to determine which metabolic signals are influenced 
by food intake [16]. The complexity of the metabolic re-
sponse to the intake of different foods makes it challenging 
to study the relationship between the metabolome and pat-
terns of food intake. However, metabolomics allows a re-
searcher to monitor the metabolic response under a range of 
nutritional conditions and food intake. Furthermore, this 
approach promotes chemometrics as a range of factors, in-
cluding food type, geography, and race can be simplified by 
choosing a suitable algorithm. Hence, we can cluster the 
distinctive personal food patterns to simplify the data process 
[17]. For example, Peré-Trepat et al. [18] analyzed 1H-NMR 
plasma metabolic profile data with PCA and partial least 
squares discriminant analysis (PLS-DA) to analyze the 
metabolic profile of a population under 5 different food 
patterns. The authors demonstrated that the metabolic phe-
notypes associated with these dietary patterns were based 
primarily on differences in lipid and amino acid profiles in 
the plasma. This new approach to assess the relationship 
between dietary intake and metabolic profile data will allow 
greater steps to be made in merging nutritional epidemiology 
with metabolomics. Pedersen et al. [19] used 1H-NMR 
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plasma metabolic data to compare the metabolite profile of 
patients suffering from Irritable Bowel Syndrome who ate a 
non-probiotic acidified milk product to ones that ate a pro-
biotic acidified milk product. Both diets resulted in elevated 
levels of blood serum L-lactate and 3-hydroxybutyrate, com-
pounds that can be used as biomarkers after taking in high 
levels of lactate.  
1.5  Microbial metabolome 
The application of metabolomics to microbiology focuses 
primarily on microbiological assays, the metabolic path-
ways used by microorganisms, and the analysis of microbial 
biochemical reactions. Compared with the traditional mi-
crobiological assay technologies, metabolomics does not 
consider the phenotype and specific biochemical reactions, 
but instead quantifies the changes in metabolic compounds 
in microorganisms. This approach offers several advantages, 
including high speed, high throughput, and so on. Further-
more, the technology allows for excellent discrimination of 
strains with similar genetic information and distinctive path-
ogenicity. Bundy et al. [20] combined multivariate pattern- 
recognition methods with 1H-NMR to analyze the metabo-
lite profiles derived from six different Bacillus cereus strains. 
The two different ecotypes were clearly separated on the 
basis of their metabolite profiles, illustrating the utility of 
using metabolomics methods to classify pathogens on the 
basis of their expressed physiology, even when candidate 
genes could not be isolated to unambiguously distinguish 
between the two groups. 
2  Use of metabolomics in marine biology 
2.1  The study of viable but nonculturable marine  
microorganisms 
Colwell et al. [21,22] discovered a survival strategy, known 
as the viable but nonculturable (VBNC) state, that is adopt-
ed by bacteria when exposed to environmental stresses to 
prevent rapid cell death. In the VBCN state, microorgan-
isms are unable to form colonies, but the cells remain toxic 
[23,24] and transcription, which yields specific mRNA 
products [25,26], is coupled with the modification of the cell 
wall [27,28]. Furthermore, a proportion of the VBCN popu-
lation exhibited anabiosis given the proper environmental 
conditions [29]. The VBCN state can be described as the 
self-protective response to adverse environmental condi-
tions such as high salinity, high temperature, and oligotro-
phy. Although the widespread occurrence of VBCN in nature, 
particularly in the marine environment, provides abundant 
opportunities to study this special state, we still have not 
ascertained the mechanism(s) mediating this phenomenon. 
Metabolomics can be used to document the metabolic re-
sponse to environmental perturbation. This approach may 
be used to conduct metabolic profiling of normal and 
VBCN strains and identify biomarkers for VBCN. In turn, 
the data may be used to investigate the role of biosynthetic 
pathways in controlling the VBCN state. Moreover, we can 
use metabolomics to detect the presence of the compounds 
that induce the VBCN state. Thus, metabolomics is likely to 
play a prominent role in this field in the future. 
2.2  Marine active compounds (MACs) 
Marine organisms have special structures and functions to 
adapt to aspects of their environment, including high salini-
ty, high temperature, high pressure, and oligotrophic condi-
tions. Some MACs produced during growth and metabolism 
exhibit a special function for adapting to these extreme con-
ditions, and show promise for use as pharmaceuticals. A 
large number of MACs have been discovered that exhibit 
antineoplastic activity [30], antiviral activity [31], antioxi-
dant activity [32] and anti-inflammatory activity [33], and 
some have been used in clinical research [34]. However, the 
low volume of active compounds that can be extracted from 
marine organisms limits their application to the production 
of new drugs. Furthermore, the discovery of novel active 
compounds generated by marine organisms is time-con-     
suming. The concentration of specific compounds and the 
relationship with other compounds that can be determined 
using high throughput metabolomics technologies can help 
optimize the culture conditions to enhance productivity. 
Meanwhile, metabolic profiling of organisms under differ-
ent conditions will provide information about the precursors 
of specific active compounds, which can be used to under-
stand and control the processes generating the active com-
pounds. Traditional active compound screening relies on 
labor and time intensive approaches, such as biological 
screening and high throughput molecular modeling and 
docking. By using high throughput metabolomics, we can 
observe the changes in metabolic compounds in an organism 
under distinctive environments and the metabolic response 
of experimental animals treated with active compounds. 
This data can then be used to aid in the choice of novel 
MACs.  
Besides exploiting potential MACs, metabolomics also 
provides a new way to study the mechanism of action of 
MACs. Because of their potent cytotoxicity, structural di-
versity, and mechanistic complexity, MACs are rarely rec-
ognized as clinically relevant antineoplastic agents. The 
data obtained using metabolomics provides insight into the 
molecular mechanism of drugs and the enzyme or metabolic 
pathway that are targets for MACs. This information can be 
used to help modify MACs to produce new drugs. For ex-
ample, Bayet-Robert et al. [35] used proton NMR spectros-
copy-based metabolomics to unravel biochemical disorders 
induced in human MCF7 breast cancer cells by three lead 
candidate anticancer MACs. The response of MCF7 cells to 
these agents involves a number of metabolic pathways. 
Taken together, these examples illustrate the potential utility 
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of metabolomics to help investigate metabolic targets and 
develop new drugs.  
2.3  Research on the biosynthesis pathway of potent 
marine natural products 
Tetrodotoxin (TTX) 1 (Figure 1) is a potent neurotoxin that 
is responsible for fatal food poisoning caused by puffer fish. 
It is also an important probe in neurophysiological experi-
ments as it is a highly specific sodium-channel blocker. 
Despite a long history of TTX research, little is known about 
the biosynthetic origin of this unique molecule. Metabo-
lomics provides an ideal tool for us to determine the origin 
of TTX. Recently, we put forward a hypothetical biosyn-
thetic pathway for tetrodotoxin (Figure 2). Glycine was 
supposed as an initial precursor, which was enzymatic cata-
lyzed finally to form TTX. In our experiments, [14C]glycine 
was fed to TTX-producing bacteria culture medium. Fol-
lowing exhaustive purification by paper chromatography 
and HPLC, we isolated the radioactive TTX. Furthermore, 
the involvement of other precursors in the TTX biosynthetic 
pathway may be revealed using this approach.  
Marine invertebrates, particularly sponges and ascidians, 
are well known for their production of bioactive natural 
products, several of which are currently undergoing clinical 
trials [36,37]. Numerous synthetic approaches have been 
devoted to this class of compounds. However, because of 
the complexity of the structures, these approaches are not 
economically profitable. Bryostatin 1 (Figure 3), a potent 
anticancer agent, is a proposed metabolite of the B. neritina 
bacterial symbiont “Candidatus Endobugula sertula”. Alt-
hough this c-proteobacterium has not been cultivated, its 
reduction or elimination upon antibiotic treatment of labor-
atory cultured bryozoans leads to a reduction and eventual 
loss of bryostatin production in new generations of larvae 
without an effect on colony growth. Furthermore, bryostatins 
resemble bacterial type I PKS products, leading to specula-
tion that these macrolides are derived from a microbial 
symbiont [38]. Based on the analysis of the secondary me-
tabolites, a hypothetic biosynthetic pathway for bryostatin 1 
was proposed. 
2.4  Toxicology of marine heavy metal contamination 
Heavy metal pollution has become a serious threat to the 
marine environment because of the persistence, ease of 
transport, and high toxicity of these metals. Marine bivalves 
can accumulate heavy metals in direct proportion to the 
environmental levels [39]. Thus, mussels and oysters are 
often used as sentinel organisms when monitoring for heavy 
metal pollution in the marine and coastal ecosystems. The 
majority of this research focuses on the response of sentinel 
organism following exposure to a specific heavy metal. 
Traditional methodologies involve measurement of specific 
metabolic compounds (e.g., acetylcholinesterase) to docu-
ment neurotoxicity or antioxidant enzyme levels to docu-
ment oxidative stress induced by heavy metals [40,41]. 
However, it is difficult to elucidate the effect on the whole 
metabolic pathway using this approach. Using metabolomics 
affords the ability to detect large numbers of endogenous 
low molecular weight metabolites in an organ or cells, so is  
 
Figure 1  The structure of tetrodotoxin. 
 
Figure 2  Hypothetical biosynthetic pathway of tetrodotoxin. 
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Figure 3  The structure of bryostatin 1. 
a better option when investigating the mechanism(s) con-
trolling the metabolic response to marine heavy metal con-
taminants. Zhang et al. [42] studied the metabolic responses 
of Manila clam to environmentally relevant copper expo-
sures using NMR-based metabolomics. The authors showed 
that osmotic regulation and energy metabolism were dis-
turbed by exposure to copper. This example illustrates the 
value of metabolomics in the discovery of metabolic bi-
omarkers that can be used to understand the mechanistic 
pathways underlying marine heavy metal contaminant toxi-
cology. 
Other research has focused primarily on the tissue-special 
toxicological effects of heavy metal on indicator organisms. 
By investigating the distinctive metabolic profiles of dif-
ferent organs, we can establish time-dependent assessments 
for nutritional challenges and functional adaption of indica-
tors to the environment. Andrey et al. [43] identified 32 
major compounds and provided a basis for future metabo-
lomics studies of the oyster in a comprehensive NMR anal-
ysis of the Eastern oyster. Increased concentrations of bi-
omarkers were used as indicators of the main metabolic 
pathway in different organ blocks, providing reference in-
formation for tissue-specific toxicity. Similarly, Wu et al. 
[44] investigated the toxicological effects of Cadmium (Cd) 
in both the digestive gland and adductor muscle tissue of the 
green mussel (Perna viridis). The adductor muscle tissue 
was characterized by elevated levels of acidic amino acids 
and reduced levels of branched chain amino acids. These 
observations suggest that the adductor muscle tissue of 
mussels is a suitable supplemental biomarker for exposure 
to toxicants. 
2.5  Cyanobacteria energy production  
The drawback of traditional fossil fuels, including oil, coal, 
and natural gas, is their finite supply, which will be depleted 
in the relatively near future. The management and storage of 
nuclear wastes limit the worldwide use of nuclear power. 
Given this, scientists have begun to turn to new resources to 
exploit renewable and clean energy. Among the candidate 
resources, cyanobacteria have drawn increasing attention 
because of the ease with which they can be cultured and 
genetically modified. Cyanobacteria, being photosynthetic 
organisms, use solar energy, H2O, and CO2 to synthesize 
their energy storage components (i.e., carbohydrates, lipids, 
and proteins). The carbohydrates may be transformed to 
ethanol by fermentation under dark, anoxic conditions [45]. 
The carbohydrates, lipids, and proteins produced by cyano-
bacteria can be converted to CH4 gas when they are cultured 
in conditions favoring anaerobic digestion [46]. Further-
more, many strains of cyanobacteria can produce hydrogen 
by the reversible activity of hydrogenase [47,48]. The focal 
point of current research is the identification of new strains 
with specific metabolic traits for optimizing cultivation 
conditions in bioreactors. Thus, the comprehensive infor-
mation provided by metabolomics can also be used as sup-
plementary data to improve renewable energy production. 
Using these techniques, researchers can identify specific 
enzymes or biomarkers to modify energy metabolic path-
ways or change the culture conditions according to the re-
sponse of cyanobacteria to external stimuli. Although 
metabolomics has not been widely used in this field, there is 
considerable potential for its use in the study of cyanobacte-
ria energy production.  
2.6  The treatment and prevention of aquatic diseases 
Poor management and breeding conditions are generally 
associated with an increase in the incidence of disease, 
which directly affects the growth and survival of cultured 
organisms. Cross-infection is common with aquatic diseases 
and infections are often difficult to treat. Thus, the key to 
sustainable production is in the prevention of disease. 
However, there remain difficulties in diagnosis due to the 
ambiguous nature of early symptoms. In this instance, 
metabolomics may be used to identify differences in the 
metabolic profiles of healthy and sick animals, in a rela-
tively non-invasive procedure.  
3  Metabolomics approaches 
3.1  Analytical methodology for metabolomics 
Metabolomics relies primarily on NMR and MS. The latter 
method is combined with LC or GC with precolumn deri-
vatization as a supplementary means to separate the meta-
bolic compounds. MS may also be combined with other 
separation methods such as capillary electrophoresis (CE), 
Fourier transform infrared spectroscopy (FT-IR), and array 
electrochemical detection. 
(i) NMR.  High throughput NMR yields information on 
hundreds of compounds with each measurement. The dis-
tribution of an individual signal is dependent on the chemi-
cal atmosphere around the nucleus. Thus, NMR provides a 
large volume of structural information to describe metabolic 
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compounds. However, the conditions of the solution (e.g., 
pH and ionic strength) have a significant influence on the 
observed spectrogram. NMR is the best choice for metabol-
ic profiling because of the presence of different isotopes and 
the ubiquitous hydrogen bonds in biological molecules. A 
range of isotopes can be detected, including 1H, 13C, 31P and 
15N, though 1H-NMR is used most commonly. Some re-
searchers have already used “inverse” methods of detection 
to detect compounds with low natural abundance or poor 
magnetic sensitivity. For example, the information generat-
ed by two or more dimensional data from different nuclei on 
the same molecule can be combined [49,50]. 
The decay of the NMR signal is highly sensitive to mo-
lecular dynamics. Lindon et al. [51] used the elimination of 
resonances to show the slowly tumbling proteins and lipo-
proteins in plasma or serum. Although NMR has lower sen-
sitivity in practical applications when compared with 
LC-MS, the limitation of detection and the sample volume 
demanded for analysis is very low. This provides an ad-
vantage for analyzing mass limited circumstances or a large 
quantity of samples. Nowadays, automatic sample handling 
systems can be coupled with NMR to analyze hundreds of 
samples automatically with high accuracy and reproducibi-    
lity per day [52].  
Magic Angle Spinning NMR (MAS-NMR) involves the 
detection of intact tissues and cells with little or no prepara-
tion [53,54]. MAS-NMR significantly reduces the effect of 
magnetic field inhomogeneity in ordered materials. However, 
the peaks obtained from MAS-NMR are always broad and 
distorted. Thus this approach is not able to provide detailed 
information about the metabolic compounds in samples. 
However, the metabolic profile detected by MAS-NMR can 
be used to document the changes in metabolic compounds 
in intact tissue following exposure to toxins under different 
cellular conditions [55]. The ability to localize biochemical 
changes to a specific tissue, cell type, or organelle provides 
valuable information associated with the mechanism of tox-
icity and supplementary interpretation of biofluid analyses 
[3]. In conclusion, MAS-NMR provides an approach to 
validate and study the internal metabolic response to toxins 
in vitro. 
(ii) GC-MS and LC-MS.  In addition to having higher 
sensitivity than NMR, the distribution of signals in an MS 
spectrogram is dependent on the molecular mass. Thus, the 
MS spectrogram provides excellent discrimination and 
complete structural information. FT-MS (Fourier Transform 
MS) can be used for accurate mass determination to control 
the precision under one per million. To obtain additional 
structural information for a specific molecule, we can in-
crease the energy of electron bombardment to generate 
more fragments of the parent molecule. The molecular 
structure can be rebuilt by comparison of the information 
from fragments and the standard spectrogram. However, the 
relationship between the concentration of metabolic com-
pounds and the strength of peaks in the MS spectrogram is 
not linear, and because of ion suppression, the sensitivity is 
dependent on the presence of other compounds in the matrix. 
Some common separation approaches, such as GC and LC, 
are used to reduce the matrix effect. Recently, researchers 
used capillary electrophoresis as a supplementary approach 
to reduce the matrix effect [56]. This increases the chemical 
discrimination of different metabolic compounds and pro-
vides convenience when investigating metabolic profiles.  
Most of the samples prepared for MS require derivatiza-
tion because of the phase state of the mobile phase. This 
requires additional time and may cause transformation of 
the sample. The derivatization of MS limits the application to 
the analysis of heat sensitive substances and high-molecular- 
weight metabolic compounds. However, GC-MS has high 
analytical speed and separation efficiency. Comparatively 
speaking, LC-MC is suitable for the detection of unstable, 
non-volatile, and high-molecular-weight compounds without 
derivatization. However, it is also time-consuming and has 
low separation efficiency. The identification of compounds 
always requires further analysis because there is no standard 
database for searching and comparison.  
(iii) Hyphenation.  When combined with other separa-
tion technologies, MS has the advantages of rapid identifi-
cation and detection of a range of compounds. However, the 
requirement that the output needs to be compared with 
standard database limits its application to detect unknown 
compounds. NMR can provide an atraumatic and reproduc-
ible approach to identify and quantify metabolic compounds, 
although it may be difficult to identify overlapping signals 
in complex compounds. As a result, the physical combina-
tion of multiple analytical technologies, or “hyphenation”, 
has become a popular means of overcoming the disad-
vantages of each of these technologies. Since the Bruker 
interface combines NMR and MS, both methods have 
online analytical software that is able to offer the compre-
hensive structural data. High pressure Liquid Chromatog-
raphy–diode array detector-solid phase extraction–NMR-MS 
(HPLC-DAD-SPE-NMR-MS) using Cryoflow Probes™ have 
also become more important for the analysis of complex 
samples [57]. In addition to being used to identify the 
structure of natural products, HPLC-DAD-SPE-NMR-MS 
can also be used to detect the metabolic response to drugs 
[58] and identify the compounds present in biofluid [59]. 
Besides the online system, integrated data can also be ob-
tained by using different technologies in parallel. Chan et al. 
[60] used HR-MAS NMR and GC-MS to identify 31 marker 
metabolites in biopsied colorectal tumors and their matched 
normal mucosa obtained from 31 colorectal cancer (CRC) 
patients. The orthogonal partial least squares discriminant 
analysis (OPLS-DA) model generated from metabolic pro-
filing can further differentiate colon from rectal cancers, 
providing new biomarkers for the diagnosis of CRC. Smilde 
et al. [61] combined GC-MS and LC-MS data to analyze the 
metabolic compounds of E. coli NST74 cultured under dif-
ferent nutritional conditions. This example illustrates how 
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this technology can be used to provide a comprehensive view 
of the metabolome of a microorganism [61].  
3.2  Strategies for metabonomic data analysis 
The key point of strategies for metabolomics data analysis 
lies in how to use “pattern recognition (PR)” to process the 
“raw” data [62]. Assuming the metabolic profile of two 
samples generated from a series of measurement is the same; 
the two samples are analogous. The central application of 
PR is the determination of the appropriate index of similar-
ity. After determining the appropriate index of similarity, 
we can identify normal and abnormal metabolic profiles of 
samples under distinctive dysfunction and experimental 
control. Pattern recognition algorithms differ widely in both 
a general way in which variables are combined to generate a 
final output or model and in approaches to how a specific 
model is derived [3]. Unsupervised methods, such as PCA 
and self-organizing maps (SOMs), primarily rely on clus-
tering and visible data to reveal the internal relationship and 
structure of the data. Conversely, supervised methods such 
as discriminant function analysis (DFA) and nonlinear re-
gression take advantage of a given metabolic profile to es-
tablish a standard mode to predict the existence of specific 
metabolic data.  
Beyond pattern recognition, there are other approaches to 
generate a functionally relevant model. For example, de-
velopment modeling approaches reveal information about a 
living system with respect to the flux through metabolic 
pathways (metabolic flux/control analysis or MFA/MCA) 
[63]. These methods have been used successfully to analyze 
prokaryotic systems and eukaryotic microorganisms.  
4  Conclusions 
With the completion of the “Human Genome Project”, re-
searchers have obtained a large volume of information as-
sociated with a complex biological system. As the endpoint 
for genomics and proteomics, metabolomics combines the 
messages from higher levels of the hierarchy into an inte-
grated system. Metabolomics offers noninvasive, rapid, 
accurate, and high throughput analysis, so is ideal for use in 
a range of biological fields. The processing of complex 
metabolic data improves the development of stoichiometry 
and bioinformation. Thus, metabolomics will play an in-
creasingly important role in the future. 
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